Stephen Hatfield

3.8k total citations · 2 hit papers
41 papers, 3.1k citations indexed

About

Stephen Hatfield is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Stephen Hatfield has authored 41 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 20 papers in Physiology and 12 papers in Molecular Biology. Recurrent topics in Stephen Hatfield's work include Adenosine and Purinergic Signaling (20 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (5 papers). Stephen Hatfield is often cited by papers focused on Adenosine and Purinergic Signaling (20 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (5 papers). Stephen Hatfield collaborates with scholars based in United States, Mexico and France. Stephen Hatfield's co-authors include Neal W. Roehm, Michail V. Sitkovsky, George H. Rodgers, Andrew L. Glasebrook, Jon R. Schmidtke, Bryan Belikoff, Dmitriy Lukashev, Akio Ohta, Robert Abbott and Phaethon Philbrook and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen Hatfield

40 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT

1991 867 citations Neal W. Roehm, George H. Rodgers et al. profile →
Immunological mechanisms of the antitumor effects of supplemental oxygenation

2015 473 citations Stephen Hatfield, Jørgen Kjaergäard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Hatfield United States	24	1.1k	966	638	620	497	41	3.1k
Bing Du China	32	548 0.5×	1.3k 1.3×	458 0.7×	296 0.5×	195 0.4×	100	2.8k
Jorge Lloberas Spain	40	1.8k 1.6×	2.4k 2.5×	733 1.1×	424 0.7×	368 0.7×	77	5.3k
Fengyi Wan United States	26	995 0.9×	2.0k 2.1×	436 0.7×	359 0.6×	516 1.0×	47	4.3k
Lixin Wang China	36	1.3k 1.2×	2.3k 2.4×	809 1.3×	242 0.4×	399 0.8×	153	5.2k
Guobo Shen China	27	778 0.7×	1.6k 1.7×	681 1.1×	120 0.2×	389 0.8×	74	3.2k
Lavinia Vittoria Lotti Italy	32	1.0k 0.9×	1.8k 1.8×	473 0.7×	245 0.4×	219 0.4×	69	3.8k
Stefan F. Martin Germany	44	2.7k 2.3×	1.0k 1.1×	307 0.5×	266 0.4×	141 0.3×	129	5.6k
Klaas Poelstra Netherlands	42	710 0.6×	1.7k 1.8×	621 1.0×	191 0.3×	200 0.4×	155	5.2k
Haidong Xu China	33	742 0.6×	1.5k 1.6×	333 0.5×	130 0.2×	780 1.6×	65	3.5k
Fulvio Della Ragione Italy	36	252 0.2×	2.0k 2.1×	742 1.2×	144 0.2×	425 0.9×	122	3.9k

Countries citing papers authored by Stephen Hatfield

Since Specialization

Citations

This map shows the geographic impact of Stephen Hatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Hatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Hatfield more than expected).

Fields of papers citing papers by Stephen Hatfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Hatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Hatfield. The network helps show where Stephen Hatfield may publish in the future.

Co-authorship network of co-authors of Stephen Hatfield

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Hatfield. A scholar is included among the top collaborators of Stephen Hatfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Hatfield. Stephen Hatfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashmi, Sara M., et al.. (2025). Polymer oxidation: A strategy for the controlled degradation of injectable cryogels. Materials Today Bio. 32. 101743–101743. 4 indexed citations

Williamson, Laura, Kelly Ward, Laura Rosenberg, et al.. (2025). Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia–induced immunosuppression. JCI Insight. 10(6). 6 indexed citations

Gomari, Mohammad Mahmoudi, et al.. (2025). Breaking barriers: Smart vaccine platforms for cancer immunomodulation. Cancer Communications. 45(5). 529–571. 4 indexed citations

Dongre, Anushka, et al.. (2022). Targeting Hypoxia‐Adenosinergic Signaling to Enable Effective Anti‐Tumor Responses by Reprogramming the Immunosuppressive Tumor Microenvironment. The FASEB Journal. 36(S1).

Colombani, Thibault, Loek J. Eggermont, Stephen Hatfield, et al.. (2021). Oxygen‐Generating Cryogels Restore T Cell Mediated Cytotoxicity in Hypoxic Tumors. Advanced Functional Materials. 31(37). 31 indexed citations

Hatfield, Stephen, et al.. (2020). Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy. Frontiers in Immunology. 11. 570041–570041. 35 indexed citations

Hatfield, Stephen, et al.. (2020). Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy. Current Opinion in Pharmacology. 53. 84–90. 19 indexed citations

Sorrentino, Claudia, Fokhrul Hossain, Paulo C. Rodrı́guez, et al.. (2019). Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells. Frontiers in Immunology. 10. 162–162. 59 indexed citations

Hatfield, Stephen, et al.. (2019). Mechanistic Justifications of Systemic Therapeutic Oxygenation of Tumors to Weaken the Hypoxia Inducible Factor 1α-Mediated Immunosuppression. Advances in experimental medicine and biology. 1136. 113–121. 25 indexed citations

10.

Kjaergäard, Jørgen, Stephen Hatfield, Graham B. Jones, Akio Ohta, & Michail V. Sitkovsky. (2018). A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression. The Journal of Immunology. 201(2). 782–791. 101 indexed citations

11.

Silva, Murillo, Thao H. Nguyen, Phaethon Philbrook, et al.. (2017). Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes. Cell Reports. 21(13). 3672–3680. 22 indexed citations

12.

Abbott, Robert, Murillo Silva, Derek W. Cain, et al.. (2017). The GS Protein-coupled A2a Adenosine Receptor Controls T Cell Help in the Germinal Center. Journal of Biological Chemistry. 292(4). 1211–1217. 25 indexed citations

13.

Hatfield, Stephen & Michail V. Sitkovsky. (2015). Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulators. OncoImmunology. 4(12). e1052934–e1052934. 23 indexed citations

14.

Hatfield, Stephen, Jørgen Kjaergäard, Dmitriy Lukashev, et al.. (2014). Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection. Journal of Molecular Medicine. 92(12). 1283–1292. 165 indexed citations

15.

Lee, Joslynn S., Kaisa Selesniemi, Stephen Hatfield, et al.. (2013). Design and evaluation of xanthine based adenosine receptor antagonists: Potential hypoxia targeted immunotherapies. Bioorganic & Medicinal Chemistry. 21(23). 7453–7464. 10 indexed citations

16.

Belikoff, Bryan, Stephen Hatfield, Michail V. Sitkovsky, & Daniel G. Remick. (2010). Adenosine Negative Feedback on A2A Adenosine Receptors Mediates Hyporesponsiveness in Chronically Septic Mice. Shock. 35(4). 382–387. 27 indexed citations

17.

Hatfield, Stephen & Neal W. Roehm. (1992). Cyclosporine and FK506 inhibition of murine mast cell cytokine production.. Journal of Pharmacology and Experimental Therapeutics. 260(2). 680–688. 63 indexed citations

18.

Hatfield, Stephen & George H. Rodgers. (1991). Atterns of Lymphokine Production by Primary Antigen-Specific/MHC Restricted Murine Helper T Cell Clones. Immunological Investigations. 20(1). 55–73. 4 indexed citations

19.

Hatfield, Stephen, B H Petersen, & J.A. DiMicco. (1986). Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 460–466. 38 indexed citations

20.

Schmidtke, Jon R. & Stephen Hatfield. (1976). Activation of purified human thymus-derived (T) cells by mitogens. II. Monocyte- macrophage potentiation of mitogen-induced DNA synthesis.. PubMed. 116(2). 357–62. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact